GLN-URSODIOL
Identification of Gln-Ursodiol
| No description |
Google image searchProduct monograph
Active ingredient
ursodiol, 250 MG
DIN: 02426900
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: GLENMARK PHARMACEUTICALS CANADA INC.
Date: 23-JUL-2021
ATC:
- A05 — BILE AND LIVER THERAPY (ATC, ATC/DDD, )
- A05A — BILE THERAPY (ATC, ATC/DDD)
- A05AA — Bile acid preparations (ATC, ATC/DDD)
- A05AA02 — URSODEOXYCHOLIC ACID (ATC/DDD)
Reference brand drug: Urso
Pharmaceutical standard: USP
